Sunday , October 22 2017
Home / David L. Joffe, BSPharm, CDE, FACA (page 12)

David L. Joffe, BSPharm, CDE, FACA

David L. Joffe, BSPharm, CDE, FACA
(Editor-in-Chief Diabetes In Control) A graduate of University of Kentucky College of Pharmacy, he has practiced in the Tampa Bay area since 1986, has been providing diabetes and cardiovascular care in Tampa Bay since 1995, and spent 2 years as an Eckerd Patient Care Pharmacist managing over 100 diabetes patients. Dave currently sees patients in over 30 primary care and endocrinologists offices.

Oct. 25, 2016

dave

Glucagon gets a lot of mentions when we talk about diabetes. We take metformin to stop glucagon release; we inject glucagon when a patient is so hypoglycemic they are passed out. We even use glucagon-like peptide to treat diabetes. But exactly what is glucagon, where does it come from, and how ...

Read More »

Oct. 22, 2016

The A1c has become the gold standard in diabetes care evaluation. It is quick, it is easy, and it requires only one stick every 3 months. The only downside is that it is an average, and so many people get a false sense of control because their “average” glucose is ...

Read More »

Oct. 20, 2016

dave

The kidney is one of the most studied organs in the body, and is affected by many diseases. Even food can have an effect on proper renal function. When things go wrong in the kidney, we at times see a cascade of problems that get worse as time goes by. ...

Read More »

Oct. 18, 2016

dave

After years of trying to figure out why the most tightly managed patient will just all of a sudden lose control, we have discovered that it is due to the parasympathetic, sympathetic, and sensory nerves that innervate the pancreatic islets. This knowledge is already being used to develop new drugs for ...

Read More »

Oct. 15, 2016

dave

I am sure you have heard of the driverless Uber cars that will shortly populate the highways delivering food, passengers, and most likely, Amazon packages. This morning I heard that long haul trucks will run on the same autopilot system, except there will be a driver in the cab for when the system can’t handle the narrow ...

Read More »

Oct. 11, 2016

dave

“You can’t cure me, ’cause there ain’t nothing wrong with me!!” If I only had a dollar for every time one of my patients told me this. What makes these ridiculous statements even harder to believe is that many patients will do everything properly to take care of themselves, and ...

Read More »

Oct 10, 2016

dave

In November of 2007 we ran a small article on the use of fast acting bromocriptine to reset the metabolic clock in patients with diabetes. This article caused us to receive a lot of questions on how the drug worked, and one of our PharmD candidates prepared a great article on ...

Read More »

Oct. 8, 2016

dave

This week the take home message asks us to change from “start low and go slow,” to “be aggressive not repressive.” More and more documentation shows the value of adding newer classes of medications sooner to get our patients to target. Part of this comes from the sheer acknowledgement that ...

Read More »

Oct. 4, 2016

dave

There are often times when I don’t know which of the features to select to comment on in the Editor’s Desk. This week is one of those weeks. The topics are diverse, and it is hard to see every subject appealing to every reader. If you are a science person, ...

Read More »